Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

AMS vs SNDA: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

SNDA Captures Overall Composite Edge (44.1 HOLD vs 33.8 SELL), While AMS Leads 3–2 on Growth & Valuation Pillars

SNDA Overall Winner 6-Pillar Tally: AMS 3 – 2 SNDA (1 Tie) Matrix Metrics: AMS 5 – 5 SNDA

As of Nov 16, 2026, Sonida Senior Living, Inc. (SNDA) captures the overall head-to-head institutional edge over American Shared Hospital Services (AMS) on higher Unified Composite conviction (44.1/100 HOLD vs. 33.8/100 SELL) after splitting the core matrix 5–5 (led by Growth & Scale, Balance Sheet & Cash Flow), while AMS wins 3–2 across the 6-pillar growth and valuation breakdown. AMS trades at $1.07 (44.6x Forward P/E, -7.4% operating margin) versus SNDA at $32.90 (57.1x Forward P/E, -3.1% operating margin).

  • Growth vs. Quality Trade-Off: SNDA earns the overall head-to-head edge with a stronger Unified Composite Score (44.1/100 HOLD vs. AMS 33.8/100 SELL) and 0.49β · 49% Vol risk profile, whereas AMS leads top-line expansion (+19.2% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.
  • Technical & Structure Timing Caution: AMS is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 27.1); meanwhile SNDA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 40.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About AMS vs SNDA
AMS NYSE American
American Shared Hospital Services
Services-Medical Laboratories
$1.07
-0.93% 1D
Market Cap $7.2M
TTM Revenue $30M
Forward P/E 44.6x
Beta / 30D Vol 0.18β · 46% Vol
Unified Composite Score
33.8 / 100 SELL
Tech 24.0 Fund 38.0 Flow 50.0 Mom 30.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -7.9%), weak momentum, RSI 27
RSI-14: 27.1 · SMA20: $1.21 · SMA50: $1.32
SNDA NYSE Head-to-Head Winner
Sonida Senior Living, Inc.
Services-Nursing & Personal Care Facilities
$32.90
-0.3% 1D
Market Cap $1.6B
TTM Revenue $594M
Forward P/E 57.1x
Beta / 30D Vol 0.49β · 49% Vol
Unified Composite Score
44.1 / 100 HOLD
Tech 47.0 Fund 52.0 Flow 50.0 Mom 58.9
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -5.6%), weak momentum, RSI 41
RSI-14: 40.9 · SMA20: $33.79 · SMA50: $36.03

6-Pillar Scorecard Institutional Category Breakdown (AMS 3 – 2 SNDA)

Columns: Metric · AMS · SNDA
1. Valuation Multiples AMS
Forward P/E 44.6x 57.1x
Trailing P/E 44.6x 57.1x
PEG Ratio N/M 2.04x
EV / Revenue 0.8x 2.7x
2. Growth & Scale SNDA
Revenue Growth (YoY) +19.2% +131.2%
Earnings Growth (YoY) -38.1% -21.7%
TTM Revenue (USD) $30M $594M
Market Cap $7.2M $1.6B
3. Profitability & Quality AMS
Gross Margin 34.8% 29.4%
Operating Margin -7.4% -3.1%
Net Profit Margin -5.8% -21.9%
Return on Equity (ROE) -12.1% -27.0%
4. Balance Sheet & Cash Flow SNDA
Cash Generation (TTM) -$916,000 $103M EBITDA
Cash Flow Margin -3.0% 17.3% EBITDA Mgn
Net Cash / Leverage $17M Net Debt (0.95x D/E) $18.41 Book/Sh · -27.0% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat AMS
OpEx & R&D Intensity 42.2% of Rev ($13M) 32.5% of Rev ($193M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Medical Care Facilities Operator Medical Care Facilities Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: AMS (5) vs SNDA (5)
Institutional Metric AMS SNDA Criterion Row Edge
Market Capitalization
Scale
$7.2M $1.6B Larger Scale SNDA
Trailing P/E Ratio
Valuation
44.6x 57.1x Lower Multiple AMS
Forward P/E Ratio
Valuation
44.6x 57.1x Lower Multiple AMS
Revenue Growth (YoY)
Growth
+19.2% +131.2% Higher Growth SNDA
Operating Margin (TTM)
Profitability
-7.4% -3.1% Higher Margin SNDA
Net Profit Margin
Profitability
-5.8% -21.9% Higher Margin AMS
Return on Equity (ROE)
Capital Efficiency
-12.1% -27.0% Higher ROE AMS
52-Week Range Position
Momentum
6% ($1–$2) 22% ($30–$44) Stronger Trend SNDA
Beta / 30D Volatility
Risk Regime
0.18β · 46% Vol 0.49β · 49% Vol Lower Realized Risk AMS
Unified Institutional Score
Composite Signal
33.8 / 100 (SELL) 44.1 / 100 (HOLD) Higher Composite SNDA
Trailing 12M Revenue (USD)
Operating Scale
$30M $594M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
34.8% 29.4% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.8x EV/Rev 2.04x PEG · 2.7x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$916,000 ($17M Net Debt (0.95x D/E)) $103M EBITDA ($18.41 Book/Sh · -27.0% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon SNDA +9.64 pp
AMS: -16.41% · SNDA: -6.77%
3M Horizon SNDA +10.39 pp
AMS: -29.14% · SNDA: -18.75%
6M Horizon SNDA +12.63 pp
AMS: -23.57% · SNDA: -10.94%
1Y Horizon SNDA +55.01 pp
AMS: -52.23% · SNDA: +2.78%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AMS vs SNDA. Trailing 12-month operating profitability (AMS -7.4% vs SNDA -3.1%) and valuation multiples (AMS 44.6x vs SNDA 57.1x Forward P/E) are benchmarked directly in Pillar 4 below.

AMS ADR TTM Benchmark FX-Normalized USD
TTM Revenue$30M
Gross Margin34.8%
Op. Margin-7.4%
ROE / Fwd P/E-12.1% · 44.6x
SNDA ADR TTM Benchmark FX-Normalized USD
TTM Revenue$594M
Gross Margin29.4%
Op. Margin-3.1%
ROE / Fwd P/E-27.0% · 57.1x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
AMS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact AMS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
SNDA UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact SNDA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
AMS Moat Profile Cyclical / Execution-Driven Positioning
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $7.2M market capitalization and -7.4% operating margin.
OpEx & R&D Reinvestment 42.2% of Rev ($13M)
90D Engineering Disclosures 0 Published
Mapped Supply-Chain Ecosystem (18 partners):
Taiwan Semiconductor Manufacturing Company GlobalFoundries ASE Technology Holding Amkor Technology
SNDA Moat Profile Cyclical / Execution-Driven Positioning
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $1.6B market capitalization and -3.1% operating margin.
OpEx & R&D Reinvestment 32.5% of Rev ($193M)
90D Engineering Disclosures 0 Published

Investor FAQ AMS vs SNDA Key Questions & Quantitative Answers

As of Nov 16, 2026, Sonida Senior Living, Inc. (SNDA) captures the overall head-to-head institutional edge over American Shared Hospital Services (AMS) on higher Unified Composite conviction (44.1/100 HOLD vs. 33.8/100 SELL) after splitting the core matrix 5–5 (led by Growth & Scale, Balance Sheet & Cash Flow), while AMS wins 3–2 across the 6-pillar growth and valuation breakdown. AMS trades at $1.07 (44.6x Forward P/E, -7.4% operating margin) versus SNDA at $32.90 (57.1x Forward P/E, -3.1% operating margin). Growth vs. Quality Trade-Off: SNDA earns the overall head-to-head edge with a stronger Unified Composite Score (44.1/100 HOLD vs. AMS 33.8/100 SELL) and 0.49β · 49% Vol risk profile, whereas AMS leads top-line expansion (+19.2% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: AMS is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 27.1); meanwhile SNDA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 40.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

SNDA leads the Growth & Scale pillar: AMS posts +19.2% YoY revenue growth and -38.1% YoY earnings growth on $30M TTM revenue (34.8% gross margin, -7.4% operating margin), compared with SNDA at +131.2% YoY revenue growth and -21.7% YoY earnings growth on $594M TTM revenue (29.4% gross margin, -3.1% operating margin). On trailing 12-month operating scale, AMS generates $30M in USD-normalized revenue versus $594M for SNDA. In operating R&D and SG&A reinvestment, AMS deploys 42.2% of Rev ($13M) (0 90-day corporate R&D disclosures) versus 32.5% of Rev ($193M) (0 disclosures) for SNDA.

AMS screens cheaper on headline valuation multiples. AMS trades at 44.6x Forward P/E, 44.6x Trailing P/E, N/M PEG, and 0.8x EV/Revenue (-3.0% FCF margin), whereas SNDA trades at 57.1x Forward P/E, 57.1x Trailing P/E, 2.04x PEG, and 2.7x EV/Revenue (17.3% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AMS (-12.1% ROE) versus SNDA (-27.0% ROE) capital efficiency.

In options market volatility and institutional positioning, AMS carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.18β · 46% Vol realized risk). By comparison, SNDA carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.49β · 49% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.